“astellas-pharma” Archives

in
Entry Author Date Location
Biotech Roundup: FDA Culpa, Tricida Trips, Freenome’s Funding & More 08/28/20 National
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases 08/26/20 Boston
Astellas Reports Third Patient Death in Audentes Gene Therapy Study 08/21/20 San Francisco
Gilead Sciences Splashes Out $300M for Tizona Stake & Option to Acquire 07/21/20 San Francisco
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
Pandion Pulls In $80M as Ulcerative Colitis Drug Advances in Clinic 04/01/20 Boston
Bio Roundup: Clinical Trials Paused, New MS Drug, Kallyope’s Cash & More 03/27/20 National
CytomX Lands $80M to Kick Off Cancer Drug R&D Pact With Astellas 03/24/20 San Francisco
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More 01/03/20 National
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal 12/03/19 San Francisco
Astellas Bets On Gene Therapy With $3B Audentes Acquisition Offer 12/03/19 National
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Biotech Roundup: Gottlieb v. Juul, Solid Slumps, Avidity Gets $100M & More 11/15/19 National
Biotech Roundup: Novartis on Hold, AMAG Vote, Neuro News & More 11/01/19 National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Urovant Bladder Drug Hits Test Goals But Can’t Outpace Generic Rival 03/19/19 San Diego
Bio Roundup: Brii Does China, Hemophilia Updates, Right to Try & More 05/25/18 National
Astellas Buys Stem Cell Gene-Editing Firm Universal Cells for $102.5M 02/14/18 Seattle
Bio Roundup: Wilson’s Warning, Amazon’s Health Biz, Moderna Cash & More 02/02/18 National
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies 03/21/17 San Francisco
Starting a Medtech Company? Try Skipping Venture Capital, VCs Say 02/14/17 Texas
FibroGen Pushes Forward With Anemia Pill in China, But Big Test Awaits 01/30/17 San Francisco
Podium Data Downloads $9.5M to Help Businesses Manage, Crunch Data 09/26/16 Boston
Pfizer Shells Out $14B to Win Medivation Sweepstakes 08/22/16 San Francisco
OncoGenex Hires Advisor, Evaluates Options As Cancer Drug Fails Again 08/16/16 Seattle
Cytokinetics Gets $95M in First ALS Deal, Needs Results For More 07/27/16 San Francisco
Tokai Pharma Shutters Prostate Cancer Drug Trial Early, Shares Crumble 07/26/16 Boston
In M&A Bonanza, AbbVie, Sanofi Throw Billions at Stemcentrx, Medivation 04/28/16 San Francisco
Page 1 of 4 next page »